The effect of education on adherence to tuberculosis therapy

I. Dilek, F. Ozseker, G. Can, E. Damadoglu, U. Bayram, E. Akkaya (Istanbul, Turkey)

Source: Annual Congress 2004 - Management of infection and tuberculous diseases I
Session: Management of infection and tuberculous diseases I
Session type: Thematic Poster Session
Number: 3944
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Dilek, F. Ozseker, G. Can, E. Damadoglu, U. Bayram, E. Akkaya (Istanbul, Turkey). The effect of education on adherence to tuberculosis therapy. Eur Respir J 2004; 24: Suppl. 48, 3944

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Choice and adherence in preventive treatment for tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008

Effect of HIV counseling and testing program on patients‘ adherence of isoniazid preventive therapy (IPT)
Source: Eur Respir J 2005; 26: Suppl. 49, 455s
Year: 2005

Patient choice promotes adherence in preventive treatment for latent tuberculosis
Source: Eur Respir J 2007; 30: 728-735
Year: 2007



Does gender has any effect on tuberculosis diagnosis and treatment outcomes?
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

The influence of patient education on asthma treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 243s
Year: 2003

The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001

The effectiveness and safety of empirical anti-TB therapy in a population with high TB prevalence
Source: Eur Respir J 2001; 18: Suppl. 33, 468s
Year: 2001

Experience of isofon use for therapy and chemoprophylaxis of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 486s
Year: 2004

The effectiveness of patient education to improve adherence to the asthma treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016


Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


The clinical impact of adherence to therapy in airways disease
Source: Breathe, 17 (2) 210039; 10.1183/20734735.0039-2021
Year: 2021



The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen
Source: Eur Respir J 2003; 21: 785-788
Year: 2003



Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006

Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006

Impact of HIV status, CD4 count and antiretroviral treatment on tuberculosis treatment outcomes in a low-burden country
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017


Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015


The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 569-571
Year: 2015